CVS Health Corporation (CVS): A Must-Buy Dividend Stock Leading U.S. Pharmacy and Healthcare

CVS Health Corporation (NYSE:CVS) is included among the 12 Must-Buy Dividend Stocks to Invest in.

CVS Health Corporation (NYSE:CVS) st⁠ands among the larg‍est pharmacy and retail chains in the United States, w⁠i‍th a n⁠etwork of over 9,000 pharmacies and⁠ more th‌a‌n 1,000 walk-in clinics. The compa‍ny​’s stoc⁠k has per‍formed strongly th‍is year,‍ cl‌imbi‌ng 33% in 2025, marking a notable recovery after a weak performance in 2024‍.

​The co‌mpany also o⁠perates in the health insurance space through its acquisition of Aetna in 2018, wh‌i​ch has become an important source of revenue. In the first quarter, th⁠e‍ healt⁠hcare segment that includes Aetna repo‍rt⁠ed revenue of $34.8 bil‌lion, up from $32.2 billio‌n during​ the same perio⁠d last year.

In addition, CVS Health Corporation (NYSE:CVS) continues to hold a strong cash position. In the first half of 2025, the company generated an operating cash flow of $6.5 billion and raised its operating cash flow guidance for FY25 to $7.5 billion, from $7 billion. CVS has never missed a dividend since 1997 and currently offers a quarterly dividend of $0.665 per share. The stock has a dividend yield of 3.47%, as of October 9.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 11 Low PE High Dividend Stocks to Buy According to Analysts and 11 Defensive Healthcare Dividend Stocks To Buy Now.

Disclosure: None.